Production (Stage)
PDS Biotechnology Corporation
PDSB
$1.69
$0.138.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.27M | 2.83M | 3.37M | 4.16M | 3.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.11M | 7.36M | 10.18M | 8.68M | 10.10M |
| Operating Income | -9.11M | -7.36M | -10.18M | -8.68M | -10.10M |
| Income Before Tax | -9.66M | -7.95M | -10.73M | -9.20M | -10.60M |
| Income Tax Expenses | -1.17M | 0.00 | -- | -869.20K | -- |
| Earnings from Continuing Operations | -8.49M | -7.95M | -10.73M | -8.33M | -10.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.49M | -7.95M | -10.73M | -8.33M | -10.60M |
| EBIT | -9.11M | -7.36M | -10.18M | -8.68M | -10.10M |
| EBITDA | -9.09M | -7.35M | -10.16M | -8.67M | -10.08M |
| EPS Basic | -0.21 | -0.21 | -0.29 | -0.23 | -0.30 |
| Normalized Basic EPS | -0.15 | -0.13 | -0.18 | -0.16 | -0.19 |
| EPS Diluted | -0.21 | -0.21 | -0.29 | -0.23 | -0.30 |
| Normalized Diluted EPS | -0.15 | -0.13 | -0.18 | -0.16 | -0.19 |
| Average Basic Shares Outstanding | 40.52M | 37.49M | 36.81M | 36.69M | 34.82M |
| Average Diluted Shares Outstanding | 40.52M | 37.49M | 36.81M | 36.69M | 34.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |